65
Veeda Clinical Research Pvt. Ltd. Bioanalytical Method Library Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL) 1 Aprepitant Antiemetic Human Plasma K 3 EDTA LC/MS/MS API 3000 20.0 8000 2 Diclofenac Analgesic Human Plasma K 3 EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K 3 EDTA LC/MS/MS API 5500 0.10 50.0 4 Sorafenib Anticancer Human Plasma K 3 EDTA LC/MS/MS API 2000 20.0 8000 5 VIN-NCE-58PL NCE Human Plasma K 2 EDTA LC/MS/MS LCMS-8060 1.00 10000 Recently Validated Methods Page 1 of 65 For more information email: [email protected]

Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method EquipmentLLOQ

(ng/mL)

ULOQ

(ng/mL)

1 Aprepitant Antiemetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 8000

2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000

3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.10 50.0

4 Sorafenib Anticancer Human Plasma K3EDTA LC/MS/MS API 2000 20.0 8000

5 VIN-NCE-58PL NCE Human Plasma K2EDTA LC/MS/MS LCMS-8060 1.00 10000

Recently Validated Methods

Page 1 of 65 For more information email: [email protected]

Page 2: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

1Acitretin +

13 - Cis AcitretinPsoriasis Human Plasma Na Heparin LC/MS/MS API 4000 2.00 500

2Aspirin +

Salicylic acid (Sensitive)Analgesic Human Plasma K3EDTA LC/MS/MS API 4000

2.00

150

1200

10000

3

Atorvastatin +

2 - Hydroxy Atorvastatin+

4 - Hydroxy Atorvastatin+

Glimpride+

Glimpride M1 Metabolite

Antihyperlipidemic

Antidiabetic

Human Plasma K3EDTA LC/MS/MS API 4000

0.10

0.10

0.05

0.50

0.50

40

40

20

200

200

4 5-Azacitidine Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 2500

5

Bupropion +

Hydroxy Bupropion+

Erythro Bupropion +

Threo Bupropion

Antidepressant and Smoking

cessationHuman Plasma Sodium Heparin LC/MS/MS Premier XE

3.00

10.0

3.00

5.00

900

3000

900

1500

6

Bupropion +

Hydroxy Bupropion +

Erythro Bupropion +

Threo Bupropion

Antidepressant Human Plasma Na Heparin LC/MS/MS Premier XE

1.00

3.00

0.80

2.50

300

900

240

750

7 Disulfiram For Chronic Alcoholism Human Plasma Na Heparin LC/MS/MS API 3000 25.0 5000

8 Doxorubicin Metabolite (Doxorubicinol) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.25 20

9 Doxorubicin(Free) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 50.0 5000

10 Doxorubicin(Liposomal) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 250 50000

11 Doxorubicin (Total) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 250 50000

Premium Methods (Generics)

Page 2 of 65 For more information email: [email protected]

Page 3: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

12 Doxorubicin (Free) Anticancer Human Plasma K3EDTA LC/MS/MS API 5500 10.0 5000

13 Doxorubicin (Liposomal) Anticancer Human Plasma K3EDTA LC/MS/MS API 5500 150 60000

14 Ergocalciferol Vitamin D2 Human Plasma K3EDTA LC/MS/MS API 5500 0.10 100

15

Estrone Unconjugated +

Estradiol Unconjugated +

Norethindrone

Oestrogen

Oestrogen

Progestogen

Human Plasma K3EDTA LC/MS/MS API 5500

0.003

0.001

0.100

0.400

0.133

13.3

16Ethinyl Estradiol(Sensitive) +

Levonorgestrel

Oestrogen

ProgestogenHuman Plasma Na Heparin LC/MS/MS API 5500

0.001

0.100

0.250

25.0

17Equilin Total +

∆8,9-dehydroestrone TotalOestrogen Human Plasma K3EDTA LC/MS/MS API 5500

0.050

0.025

8.00

4.00

18 Estrone Total Oestrogen Human Plasma K3EDTA LC/MS/MS API 5500 0.050 15.0

19

Estrone Uncojugated +

Equilin Unconjugated +

Oestrogen Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.0030

0.0045

0.0045

0.400

0.600

0.600

20Fesoterodine +

5-OH Methyl Tolterodine Antimuscarinic Human Plasma K3EDTA LC/MS/MS API 4000

0.01

0.02

7.5

15.0

21Fingolimod +

Fingolimod PhosphateMultiple sclerosis Human Blood K2EDTA LC/MS/MS API5500 0.04 0.04

5.00

5.00

22Fingolimod +

Fingolimod phosphateMultiple sclerosis Human Blood K2EDTA LC/MS/MS API 5500

0.010

0.010

5.00

5.00

23(+)-3R 5S Fluvastatin +

(-)-3S 5R FluvastatinAntihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.60

0.60

300

300

Premium Methods (Generics)

Page 3 of 65 For more information email: [email protected]

Page 4: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

24 Fluticasone Propionate Corticosteroid Human Plasma K2EDTA LC/MS/MS LCMS-8060 0.80 pg/mL 500 pg/mL

25 Formoterol Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.0004 0.20

2613-cis-Retinoic Acid+

4-Keto 13-cis-Retinoic AcidVitamin A Human Plasma K3EDTA LC/MS/MS Premier XE

5.00

10.0

1000

2000

27 2-Hydroxy Oleic AcidSynthetic derivative of Oleic

AcidHuman Plasma Na-Heparin LC/MS/MS API 4000 25.0 25000

28R-Ibuprofen+

S-IbuprofenNSAID Human Plasma K3EDTA LC/MS/MS API 4000 1000 32000

29R-Ibuprofen +

S-IbuprofenNSAID Human Plasma K3EDTA LC/MS/MS Premier XE

200

200

70000

70000

30

Isoniazide +

Rifampicin +

25 -Desacetyl Rifampicin+

Ethambutol +

Pyrazinamide

Antitubercular Human Plasma Na Heparin LC/MS/MS API 4000

60

15

25

15

200

6000

1500

2500

1500

20000

31 Lurasidone Metabolite 14283 Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 1000

32

Metformin+

Pioglitazone+

Hydroxy Pioglitazone

Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 10.00 2400

33R-Metoprolol+

S-Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 2.00 500

34S-Methyl N, N- Diethyl dithiocarbamate

(Disulfiram Secondary Metabolite )

For Chronic Alcoholism

(Disulfiram)Human Plasma Na Heparin LC/MS/MS API 3000 5.00 1000

35RSSS -Nebivolol +

SRRR-NebivololAntihypertensive Human Plasma K3EDTA LC/MS/MS API 5500

0.020

0.020

6.00

6.00

Premium Methods (Generics)

Page 4 of 65 For more information email: [email protected]

Page 5: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

36Niacin +

Nicotinuric Acid(Metabolite)Vitamin Human Plasma K3EDTA LC/MS/MS API 4000

5.00

15.0

1000

3000

37 Paclitaxel (Free, Unbound) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 1.00 1500

38 Paclitaxel (Free) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 10.0 2000

39 Penicillamine Chelating Agent Human Plasma K3EDTA LC/MS/MS Premier XE 15.0 4000

40 PhenindioneAnticoagulant/Vitamin K

antagonistHuman Plasma K3EDTA LC/MS/MS API 4000 50.0 20000

41 Prednisolone Corticosteroid Human Plasma K3EDTA LC/MS/MS API 3000 2.00 1000

42 cis & trans-Phytonadione Vitamin K Human Plasma K3EDTA LC/MS/MS API40000.100

0.100

150

150

43R-Praziquantel +

S-PraziquantelAnthelmintic Human Plasma K3EDTA LC/MS/MS API 4000

2.00

2.00

2000

2000

44R-(+) -trans -tranylcypromine +

S-(-) -trans-tranylcypromineAntidepressant and Anxiolytic Human Plasma K3EDTA LC/MS/MS API 4000

0.100

0.200

40.0

80.0

45Trientine +

N1 -Acetyl triethylenetetramine Chelating agent Human Plasma K3EDTA LC/MS/MS API 3000

6.00

10.0

1500

2500

46

Trientine +

N1 -Acetyl triethylenetetramine +

N1,N10 -Diacetyl triethylenetetramine

Chelating agent plasma K3EDTA LC/MS/MS API3000

10.0

10.0

3.00

2000

2000

600

47

Nitroglycerin +

1, 2-Dinitroglycerin +

1, 3-Dinitroglycerin

Vasodilator Human Plasma K3EDTA LC/MS/MS API 5500

0.020

0.050

0.050

2.00

5.00

5.00

48Propranolol Total +

4-OH Propranolol Total

Beta–adrenoceptor Blocking

AgentHuman Plasma K3EDTA LC/MS/MS Premier XE 2.00 500

Premium Methods (Generics)

Page 5 of 65 For more information email: [email protected]

Page 6: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

49 Pyridostigmine Anticholinesterase Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 150

50 Rivastigmine(Sensitive)Alzheimer's & Parkinson's

DiseaseHuman Plasma K3EDTA LC/MS/MS Premier XE 0.05 20.0

Premium Methods (Generics)

Page 6 of 65 For more information email: [email protected]

Page 7: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Activity/Marker Purpose Matrix

Anti-

Coagulant Method Equipment LLOQ ULOQ

1 Nitrate

Marker For the Activity of Nitric

oxide synthase and the

production of Nitric oxide

radicals

Human Plasma K3EDTA ColourimetricMicroplate

Reader5 µM 35 µM

2 Nitrite

Marker For the Activity of Nitric

oxide synthase and the

production of Nitric oxide

radicals

Human Plasma K3EDTA ColourimetricMicroplate

Reader5 µM 35 µM

3 Anti Xa

LMWH therapy is monitored by

the ratio of anti-factor Xa and

Anti Factor IIa assay, The

amount of residual factor Xa or

Factor IIa is inversely

proportional to the amount of

heparin/LMWH in the plasma

Human Plasma Na-Citrate ChromogenicMicroplate

Reader0.1 IU/mL 1 IU/mL

4 Anti IIa

LMWH therapy is monitored by

the ratio of anti-factor Xa and

Anti Factor IIa assay, The

amount of residual factor Xa or

Factor IIa is inversely

proportional to the amount of

heparin/LMWH in the plasma

Human Plasma Na-Citrate ChromogenicMicroplate

Reader0.05 IU/mL 0.2 IU/mL

5 TFPI

Extrinsic Pathway- Tissue

Factor Pathway Inhibitor, For

Determination of heparin

Presence.

Human Plasma CTAD ELISA- ColorimetricMicroplate

Reader31.25 pg/mL 2.0 ng/mL

6 C-Peptide NA Human Serum NA ELISAMicroplate

Reader28.89 pM 1850 pM

7 G-CSF Febrile Neutropenia Human Serum NA ELISA

Microplate

Reader

SYNERGY H1

2.014 50.0

Pharmacodynamic / Pharmacokinetic / Immunogenicity Determination (Validated Kit Method)

Page 7 of 65 For more information email: [email protected]

Page 8: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Activity/Marker Purpose Matrix

Anti-

Coagulant Method Equipment LLOQ ULOQ

8 Heparin Clotting AssayTo determine the clotting time

difference in presence of LMWHHuman Plasma CTAD Clotting Assay

Coagulation

Analyzer0.15 IU/mL 1.0 IU/mL

9 IgG

Immunoglobulin- IgG, specific

Heparin antibody qualitative

detection for immunogenicity of

LMWH

Human Serum NAQualitative-ELISA

Method

Microplate

ReaderNA NA

10 IgA

Immunoglobulin- IgA, specific

Heparin antibody qualitative

detection for immunogenicity of

LMWH

Human Serum NAQualitative-ELISA

Method

Microplate

ReaderNA NA

11 IgM

Immunoglobulin- IgM, specific

Heparin antibody qualitative

detection for immunogenicity of

LMWH

Human Serum NAQualitative-ELISA

Method

Microplate

ReaderNA NA

12 IgGAM

Immunoglobulin- IgG, IgM and

IgA, specific Heparin antibodies

qualitative detection for

immunogenicity of LMWH

Human Serum NAQualitative-ELISA

Method

Microplate

ReaderNA NA

13 Insulin Aspart Antidiabetic Human Serum NA ELISA

Microplate

Reader

SYNERGY H1

15.714 pM 500 pM

14 A-H-PF4 Anti Heparin Platlate factor Human Plasma CTAD ELISA- ColorimetricMicroplate

ReaderNA NA

15 Total IronFor Estimation of total Iron

after Iron sucrose therepyHuman Serum NA Colourimetric

Microplate

Reader500 ng/mL 60000 ng/mL

16 Transferrin bound Iron(TBI)

For Estimation of transferrin

bound Iron after Iron sucrose

therapy

Human Serum NA ColorimetricMicroplate

Reader200 ng/mL 8000 ng/mL

Pharmacodynamic / Pharmacokinetic / Immunogenicity Determination (Validated Kit Method)

Page 8 of 65 For more information email: [email protected]

Page 9: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. In-House ID Matrix Anti-Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

1 VIN-NCE-001 PL-1 Human Plasma Na Heparin LC/MS/MS API 4000 0.5 500

2 VIN-NCE-001 UR-1 Human Urine NA LC/MS/MS API 4000 5.0 5000

3 VIN-NCE-002 PL Human Plasma Na Heparin LC/MS/MS API 4000 10.0 2000

4 VIN-NCE-003 PL Human Plasma Na Heparin LC/MS/MS API 4000 20.0 5000

5 VIN-NCE-004 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.020 10.0

6 VIN-NCE-005 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.50 100

7 VIN-NCE-006 PL Human Plasma Na Heparin LC/MS/MS API 3000 1.00 1000

8 VIN-NCE-007 PL Human Plasma Na Heparin LC/MS/MS API 3000 5.00 5000

9 VIN-NCE-008 PL Human Plasma K2 EDTA LC/MS/MS API 4000 0.10 100

10 VIN-NCE-008 UR Human Urine NA LC/MS/MS API 4000 1.00 1000

11 VIN-NCE-009 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.10 100

12 VIN-NCE-009 UR Human Urine NA LC/MS/MS API 4000 1.00 1000

13 VIN-NCE-010 PL Human Plasma K3 EDTA LC/MS/MS API 3000 5.00 5000

Validated Methods for New Chemical Entities

Page 9 of 65 For more information email: [email protected]

Page 10: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. In-House ID Matrix Anti-Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

14 VIN-NCE-011 PL Human Plasma Na Heparin LC/MS/MS API 3000 5.00 5000

15 VIN-NCE-012 PL Human Plasma Na Heparin LC/MS/MS API 3000 0.50 500

16 VIN-NCE-014 PL Human Plasma Na Heparin LC/MS/MS Premier XE 25.0 1000

17 VIN-NCE-013 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 500

18 VIN-NCE-015 PL Human Plasma Na Heparin LC/MS/MS API 3000 1.00 500

19 VIN-NCE-016 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.10 100

20 VIN-NCE-017 BL Human Blood Na Heparin LC/MS/MS Premier XE 0.50 100

21 VIN-NCE-018 BL Human Blood Na Heparin LC/MS/MS API 3000 3.0 1200

22 VIN-NCE-019 PL Human Plasma EDTA LC/MS/MS API 2000 10.0 250

23 VIN-NCE-020 PL Human Plasma Na Heparin LC/MS/MS API 2000 1.00 25.0

24 VIN-NCE-021 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.030 100

25 VIN-NCE-022 SK Human Skin Na Heparin LC/MS/MS API 3000 12.0 9000

26 VIN-NCE-023 PL Human Plasma Na Heparin LC/MS/MS API 3000 3.00 2400

Validated Methods for New Chemical Entities

Page 10 of 65 For more information email: [email protected]

Page 11: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. In-House ID Matrix Anti-Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

27 VIN-NCE-024 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 1000

28 VIN-NCE-025 UR Human Urine Na Heparin LC/MS/MS Premier XE 0.50 1000

29 VIN-NCE-026 PL Human Blood EDTA LC/MS/MS API 3000 0.30 200

30 VIN-NCE-027 PL Human Plasma EDTA LC/MS/MS API 4000 2.00 1000

31 VIN-NCE-028 PL Human Plasma EDTA LC/MS/MS Premier XE 5.00 3000

32 VIN-NCE-029 PL Human Plasma Na Heparin LC/MS/MS Premier XE 2.00 2500

33 VIN-NCE-030 TI Colon tissue NA LC/MS/MS API 3000 12.0 9000

34 VIN-NCE-022 CT Colon tissue NA LC/MS/MS API 3000 12.0 9000

35 VIN-NCE-031 PL Human Plasma K2EDTA LC/MS/MS API 4000 0.50 5000

36 VIN-NCE-032 PL Human Plasma K2EDTA LC/MS/MS API 5500 0.050 50.0

37 VIN-NCE-034 PL Human Plasma K2EDTA LC/MS/MS API 4000 0.005 5.50

38 VIN-NCE-038 UR Human Urine NA LC/MS/MS API 3200 1.00 1000

39 VIN-NCE-037 UR Human Urine NA LC/MS/MS API 3200 10.0 10000

Validated Methods for New Chemical Entities

Page 11 of 65 For more information email: [email protected]

Page 12: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. In-House ID Matrix Anti-Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

41 VIN-NCE-035 PL Human Plasma K2EDTA LC/MS/MS API 3200 5.00 5000

42 VIN-NCE-041 PL Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 2000

43 VIN-NCE-039PL Human Plasma K2EDTA LC/MS/MS LCMS-8060 1.00 1000

40 VIN-NCE-043 PL Human Plasma K2EDTA LC/MS/MS API 4000 2.00 1000

44 VIN-NCE-037UR Human Urine NA LC/MS/MS API 3200 10.0 10000

45 VIN-NCE-042PL Human Plasma K2EDTA LC/MS/MS LCMS-8050 0.020 10.0

46 VIN-NCE-044PL (Drug + Metabolite) Human Plasma K3EDTA LC/MS/MS Premier XE1.00

1.00

1000

1000

47 VIN-NCE-040PL Human Plasma K2EDTA LC/MS/MS LCMS-8050 1.00 1000

48 VIN-NCE-045PL Human Plasma K2EDTA LC/MS/MS LCMS-8050 0.50 2000

49 VIN-NCE-046PL (Drug + Metabolite) Human Plasma K3EDTA LC/MS/MS API 40005.00

1.00

5000

1000

50 VIN-NCE-047UR Humna Urine NA LC/MS/MS API 4000 1.00 2000

51 VIN-NCE-048PL Human Plasma K3EDTA LC/MS/MS API 3200 1.00 5000

Validated Methods for New Chemical Entities

Page 12 of 65 For more information email: [email protected]

Page 13: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. In-House ID Matrix Anti-Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

52 VIN-NCE-049PL (Drug + Metabolite) NCE Human Plasma K3EDTA LC/MS/MS0.005

0.20

5.00

20.0

53 VIN-NCE-050PL NCE Human Plasma K2EDTA LC/MS/MS 1.0 5000

54 VIN-NCE-51PL NCE Human Plasma K2EDTA LC/MS/MS0.50

0.50

1000

1000

55 VIN-NCE-52PL NCE Human Plasma K2EDTA LC/MS/MS 0.020 50.0

56 VIN-NCE-53UR NCE Human Urine NA LC/MS/MS 10.0 50.0

57 VIN-NCE-54PL NCE Human Plasma K2EDTA LC/MS/MS 50.0 20000

58 VIN-NCE-55PL NCE Human Plasma K3EDTA HPLC-UV 300µg/mL 5000µg/mL

59 VIN-NCE-56PL NCE Human Plasma K3EDTA LC/MS/MS 0.020 20.0

60 VIN-NCE-57PL NCE Human Plasma K3EDTA LC/MS/MS 1.00 1000

Validated Methods for New Chemical Entities

Page 13 of 65 For more information email: [email protected]

Page 14: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method

LLOQ

(ng/mL)

ULOQ

(ng/mL)

1

Amlodipine +

Chlorthalidone +

Telmisartan

Antihypertensive Human Plasma K3EDTA LC/MS/MS

0.10

1.00

2.00

25.0

250

500

2 Candesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS 2.00 700

3Dextromethorphan +

DextrorphanCough Suppressant Human Plasma K3EDTA LC/MS/MS

0.030

0.030

15.0

15.0

4 Doxorubicin (Free) Anticancer Human Plasma K3EDTA LC/MS/MS 10.0 5000

5 Doxorubicin (Liposomal) Anticancer Human Plasma K3EDTA LC/MS/MS 150 60000

6 Droxidopa Parkinson's disease Human Plasma K3EDTA LC/MS/MS 10.0 4000

7 Erlotinib Anticancer Human Plasma K3EDTA LC/MS/MS 10.0 2500

8 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS 5.00 2500

9 Insulin Human Antidiabetic Human Plasma K2EDTA LC/MS/MS 0.050 pg/mL 10 pg/mL

10 Iron Iron Defficiency Anaemia Human Plasma K3EDTA ICP OES 400 20000

11Lamivudine +

Tenofovir Alafenamide Antiviral Human Plasma K3EDTA LC/MS/MS

20.0

2.00

5000

500

12 Levofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS 80.0 20000

13 Levosalbutamol Ashtma Human Plasma K3EDTA LC/MS/MS 0.005 1.00

14 Magnesium Hypomagnesaemia Human Serum NA ICP OES 2000 150000

15 Methyl Prednisolone Glucocorticoid Human Plasma K3EDTA LC/MS/MS 2.00 1000

Methods Under Development / Validation

Page 14 of 65 For more information email: [email protected]

Page 15: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method

LLOQ

(ng/mL)

ULOQ

(ng/mL)

16 Nitrofurantoin Antibiotic Human Plasma K3EDTA LC/MS/MS 2.00 1000

17 Omeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS 5.00 5000

18 Ospemifene Dyspareunia Human Serum NA LC/MS/MS 5.00 2000

19Oxybutynin +

Metabolite- N-Desethyl OxybutyninAnticholinergic Human Plasma K3EDTA LC/MS/MS

0.050

0.20

20.0

2000

20 Progesterone Progestogen Human Plasma K3EDTA LC/MS/MS 0.025 50.0

21 Rabeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS 4.00 2000

22 Tizoxanide Antiparasitic Human Plasma K3EDTA LC/MS/MS 50.0 25000

23 Varenicline Nicotine Addiction Human Plasma K3EDTA LC/MS/MS 5.00 1000

Methods Under Development / Validation

Page 15 of 65 For more information email: [email protected]

Page 16: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

1 Abacavir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 30.0 7500

2 Abacavir Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 30.00 9000

3Abacavir +

LamivudineAntiviral Human Plasma K3EDTA LC/MS/MS API 3000

24.0

60.0

6000

15000

4 Abiraterone Metastatic prostate cancer Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 200

5 Acetaminophen Analgesic Human Plasma Na Heparin LC/MS/MS API 3000 300.00 20000

6 Acetazolamide Carbonic anhydrase inhibitor,

diureticHuman Plasma K3EDTA LC/MS/MS API 2000 20.00 20000

7 Acetazolamide (Sensitive)Carbonic anhydrase inhibitor,

diureticHuman Plasma EDTA LC/MS/MS API 2000 10.00 5000

8 AcetazolamideCarbonic anhydrase inhibitor,

diureticHuman Plasma K3EDTA LC/MS/MS API 2000 30.00 18000

9 Acitretin Psoriasis Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.20 300

10Acitretin+

13 - Cis AcitretinPsoriasis Human Plasma K3EDTA LC/MS/MS API 4000 5.00 500

11 Agomelatine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.005 10.0

12 Agomelatine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.005 50.0

13 Alfuzosin Benign prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS API 4000 0.050 30.0

Validated Method List (Generics)

Page 16 of 65 For more information email: [email protected]

Page 17: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

14 Alfuzosin Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.40 80

15 Aliskiren Renin inhibitor Human Plasma K3EDTA LC/MS/MS API 3000 0.30 300

16 Alosetron 5-HT3 Antagonist Human Plasma K3EDTA LC/MS/MS API 4000 0.05 20

17 Alprazolam Anxiolytic Human Plasma Na Heparin LC/MS/MS Premier XE 0.20 40

18 Allopurinol Anti gout Human Plasma K3EDTA LC/MS/MS LCMS-8050 15.0 9000

19Alverine + 4-

Hydroxy Alverine Smooth muscle relaxant Human Plasma K3EDTA LC/MS/MS LCMS-8040

0.01

0.05

3.00

15.0

20 Aminocaproic acid Bleeding Disorders Human Plasma K3EDTA LC/MS/MS API 3200 500 100000

21Amlodipine +

ValsartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000

0.100

100

10.0

10000

22Albendazole +

Albendazole SulfoxideAnthelmintic Human Plasma K3EDTA LC/MS/MS API 4000

0.20

4.00

100

2000

23 Amantadine Antiviral and an

Antiparkinsonian drugHuman Plasma K3EDTA LC/MS/MS API 2000 2.00 1000

24Ambroxol +

GauifenesinExpectorant Human Plasma K3EDTA LC/MS/MS API 4000

0.40

5.00

200

2500

25Amitriptyline+

NortriptylineAntidepressant Human Plasma K2EDTA LC/MS/MS Premier XE

0.20

0.08

120

48.0

26Amitriptyline+

NortriptylineAntidepressant Human Plasma K2EDTA LC/MS/MS Premier XE

0.20

0.09

120

48.1

Page 17 of 65 For more information email: [email protected]

Page 18: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

27Amitriptyline+

NortriptylineAntidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.20

0.050

80.0

20.0

28 Amlodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03 10.0

29

Amlodipine +

HCTZ +

Olmesartan

Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000

0.05

1.00

10.0

15.0

300

3000

30Amlodipine +

OlmesartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000

0.040

10.0

12.0

3000

31Amlodipine +

TelmisartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000

0.05

5.00

10.0

1000

32Amlodipine +

ValsartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000

0.10

40.0

12.0

4800

33 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 160 30000

34 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 200 30000

35 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 50.0 25000

36 Anastrazole Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 0.20 60

37 Apixaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400

38 Apremilast Psoriatic Arthritis Human Plasma K3EDTA LC/MS/MS Premier XE 4.00 800

39 Aprepitant Antiemetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 4000

Page 18 of 65 For more information email: [email protected]

Page 19: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

40 Aripriprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.50 400

41 Aripiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.50 200

42 Aripiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 2.00 800

43Aripriprazole +

EscitalopramAntipsychotic, Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.25

0.10

65.0

24.0

44 Armodafinil Wakefulness promoting agent Human Plasma K3EDTA LC/MS/MS API 3000 50 15000

45Artemether+

DihydroartimisninAntimalarial Human Plasma Na Heparin LC/MS/MS API 4000 3.00 360

46Artesunate +

Dihydroartemisinin Antimalarial Human Plasma K3EDTA LC/MS/MS LCMS-8040

0.800

0.800

500

500

47 Asenapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.10 20

48Aspirin +

Salicylic AcidAnalgesic Human Plasma Na Heparin LC/MS/MS API 2000 2000.00 80000

49Aspirin +

Metabolite Salicylic acidAnalgesic Human Plasma K3EDTA LC/MS/MS API 4000

4.0

100

2000

7000

50 Aspirin(Sensitive) Analgesic Human Plasma K3EDTA LC/MS/MS Premier XE 10.00 2000

51 Atenolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 8.00 2200

52 Atenolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 10.0 1500

Page 19 of 65 For more information email: [email protected]

Page 20: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

53 Atomoxetine Hyperactivity disorder (ADHD) Human Plasma EDTA LC/MS/MS API 4000 5.00 2000

54 Atorvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 200

55 Atorvastatin Antihyperlipidemic Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.50 300

56

Atorvastatin +

2 - Hydroxy Atorvastatin+

4 - Hydroxy Atorvastatin

Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 3000

0.25

0.50

0.50

50

100

100

57

Atorvastatin +

2 - Hydroxy Atorvastatin+

4 - Hydroxy Atorvastatin

Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000

0.10

0.10

0.05

100

100

50

58

Atorvastatin+

2 - Hydroxy Atorvastatin+

4 - Hydroxy Atorvastatin

Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000

0.2

0.2

0.1

200

200

100

59

Atorvastatin +

2 - Hydroxy Atorvastatin+

4 - Hydroxy Atorvastatin+

Glimpride

Antihyperlipidemic

Antidiabetic

Human Plasma K3EDTA LC/MS/MS API 4000

0.1

0.1

0.05

0.50

40

40

20

200

60 Atovaquone Antiprotozoal Human Plasma K3EDTA LC/MS/MS API 3000 100.00 20000

61 Axitinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 0.200 100

62 Axitinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.075 100

63 Azithromycin Antibiotics Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000

Page 20 of 65 For more information email: [email protected]

Page 21: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

64 Azithromycin Antibiotic Human Plasma K3EDTA LC/MS/MS API3000 5.00 2000

65 Baclofen Muscle relaxant and antispastic Human Plasma K3EDTA LC/MS/MS API 4000 5.00 1000

66 Barnidipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 0.02 10

67Benazepril +

BenazeprilatAntihypertensive Human Plasma K3EDTA LC/MS/MS API 5500

1.00

2.00

400

800

68 Bendroflumethiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 200

69 Bexarotene Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200

70 Bisoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 0.50 100

71 Budesonide Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 4.50

72 Bortezomib Anticancer Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1400

73 Bortezomib Anticancer Human Plasma Na Heparin LC/MS/MS LCMS-8040 0.225 50.0

74 Bortezomib Anticancer Human Plasma Na Heparin LC/MS/MS LCMS-8040 0.225 50.0

75 Bosentan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 50.00 5000

76 Bosentan(Sensitive ) Endothelin receptor antagonist Human Plasma K3EDTA LC/MS/MS API 4000 20.00 5000

Page 21 of 65 For more information email: [email protected]

Page 22: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

77 Brexpiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 60.0

78 Budesonide Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.015 4.50

79 Bumetanide Diuretic Human Plasma K3EDTA LC/MS/MS API 3200 1.00 200

80Bupropion +

Hydroxy BupropionAntidepressant Human Plasma K3EDTA LC/MS/MS API 3000 1.50 300

81 Buspiron Anxiolytic Human Plasma K3EDTA LC/MS/MS API 3000 0.05 5.00

82 Cabergoline Dopamine receptor agonist Human Plasma K3EDTA LC/MS/MS API 5500 0.0015 0.100

83 Canagliflozin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 6000

84Canagliflozin +

Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000

5.00

5.00

3000

3000

85 Candesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 500

86Candesartan +

Hydrochlorothiazide

Antihypertensive

DiureticHuman Plasma K3EDTA LC/MS/MS API 3000

2.0

1.0

1000

500

87 Capecitabine Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 10.00 10000

88 Captopril Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 5.00 1000

89 Carbamazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 2000 20.00 5000

Page 22 of 65 For more information email: [email protected]

Page 23: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

90 Carbamazepine Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 20.00 10000

91 Carbamazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 3200 10.0 3000

92Carbidopa+

LevodopaParkinson's disease Human Plasma K3EDTA LC/MS/MS Premier XE

2.00

20.0

400

4000

93Carbidopa +

LevodopaParkinson's disease Human Plasma K3EDTA LC/MS/MS API 5500

0.25

20.0

150

4000

94Carvedilo +

4-Hydroxyphenyl CarvedilolBeta–blocker Human Plasma K3EDTA LC/MS/MS Premier XE

0.5

0.150

100

30.0

95 Carglumic AcidCarbamoyl Phosphate

Synthetase 1 activatorHuman Plasma K3EDTA LC/MS/MS API 4000 50.0 10000

96 Cefaclor Antibacterial Human Plasma CPDA, EDTA HPLC HPLC-UV 500 50000

97 Cefaclor Antibiotic Human Plasma K3EDTA LC/MS/MS API 2000 200 20000

98 Cefadroxil Antibiotic Human Plasma CPDA, EDTA LC/MS/MS API 2000 300 60000

99 Cefadroxil Antibiotic Human Plasma K3EDTA LC/MS/MS API 2000 200 40000

100 Cefditoren Antibiotic Human Plasma K3EDTA LC/MS/MS Premier XE 25.0 5000

101 Cefixime Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 100 20000

102 Cefixime Cephalosporin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 25.00 15000

Page 23 of 65 For more information email: [email protected]

Page 24: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

103 Cefixime Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 20000

104 Cefpodoxime acid Antibacterial Human Plasma EDTA LC/MS/MS API 2000 20.0 3000

105 Cefpodoxime acid Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 200 10000

106 Cefuroxime acid Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 150 30000

107 Cefuroxime acid Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 75.0 1500

108 CelecoxibSulfa non-steroidal anti-

inflammatory drug (NSAID)Human Plasma K3EDTA LC/MS/MS API 4000 20.0 5000

109 Cephalexin Antibacterial Human Plasma EDTA HPLC HPLC-UV 200 120000

110 Cephalexin Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 500 50000

111 Cephalexin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 50.0 25000

112 Cetirizine Non-sedative Antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000

113Chlorpheniramine +

Phenylephrine

Antihistamine

Decongestant Human Plasma K3EDTA LC/MS/MS API 4000

0.10

0.05

20.0

10.0

114 Chlorthalidone Diruretic Human Plasma K3EDTA LC/MS/MS LC 8040 20.0 8000

115 Chlorthalidone Diruretic Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1000

Page 24 of 65 For more information email: [email protected]

Page 25: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

116Chlorthalidone +

TelmisartanAntihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050

1.00

2.00

250

500

117 Cinnargine Antihistamine Human Plasma EDTA LC/MS/MS Premier XE 5.00 750

118 Ciprofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 10000

119 Clarithromycin Antibacterial Human Plasma EDTA LC/MS/MS API 3000 50.0 10000

120Clarithromycin +

14(R)-hydroxy-Clarithromycin Antibacterial Human Plasma EDTA LC/MS/MS API 3000

40.0

15.0

8000

3000

121 Clarithromycin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 10.0 5000

122 Clindamycin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 10.0 8000

123Clobazam +

N-Desmethyl ClobazamAED Human Plasma K3EDTA LC/MS/MS Premier XE

5.00

1.00

1500

300

124Clomipramine +

Desmethyl ClomipramineAntidepressant Human Plasma K3EDTA LC/MS/MS API 3000

1.00

1.00

300

300

125Clomipramine +

Desmethyl ClomipramineAntidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.20

0.80

50.0

200

126Clomipramine +

DesmethylclomipramineAntidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.10

0.050

6.0

30.0

127 Clonazepam AED Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 30.0

128 Clonazepam AED Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.05 20.0

Page 25 of 65 For more information email: [email protected]

Page 26: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

129 Clonidine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.025 2.50

130 Clopidogrel Anti–platelet Human Plasma CPDA, EDTA LC/MS/MS API 2000 0.20 25.0

131 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS API 4000 0.05 10.0

132 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS API 5500 0.005 5.00

133 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 10.0

134Clopidogrel+

Clopidogrel Carboxylic acidAnti–platelet Human Plasma K3EDTA LC/MS/MS API 4000

0.05

50.0

10.0

10000

135 Clozapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 1000

136 Cyclosporin (Ciclosporin) Immunosuppressant Human Blood K3EDTA LC/MS/MS Premier XE 5.00 2000

137 Dabigratan (free) Thrombin Inhibitor Human Plasma Na-Citrate LC/MS/MS API 4000 1.00 300

138 Dalfampridine Multiple sclerosis Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.40 100

139 Dapsone Antileprotic Human Plasma K3EDTA LC/MS/MS API 4000 25.0 5000

140Dapsone +

N-Acetyl DapsoneAntileprotic Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.045

0.015

18.0

6.00

141 S-DapoxetineSelective serotonin reuptake

inhibitorHuman Plasma EDTA LC/MS/MS API 4000 1.00 1000

Page 26 of 65 For more information email: [email protected]

Page 27: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

142 Darifenacin Urinary incontinence Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 5.00

143 Darifenacin Urinary incontinence Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 12.0

144 Darunavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 20000

145 Dasatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400

146 Dasatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 1.00 400

147 Deferasirox Iron Chelator Human Plasma K3EDTA LC/MS/MS API 2000 100 60000

148Deferiprone +

Deferiprone GlucuronideIron Chelator Human Plasma Na Heparin LC/MS/MS API 2000

250

125

40000

20000

149 Desipramine Antidepressant Human Plasma K3EDTA LC/MS/MS API4000 0.50 150

150Desipramine +

2-Hydroxy DesipramineAntidepressant Human Plasma K3EDTA LC/MS/MS API 4000

0.5

0.15

150

45

151 Desloratadine Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 10.0

152Desloratadine +

3-Hydroxy DesloratidineAntihistamine Human Plasma K3EDTA LC/MS/MS API 4000 0.05 10.0

153Desloratidine +

3-Hydroxy DesloratidineAntihistamine Human Plasma EDTA LC/MS/MS API 4000 0.05 10.0

154Desloratidine +

3-Hydroxy desloratidineAntihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050

25.0

25.0

7500

7500

Page 27 of 65 For more information email: [email protected]

Page 28: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

155 DesmopressinSynthetic replacement of

vasopressin harmone Human Plasma K3EDTA LC/MS/MS APi5500 0.002 0.025

156 Desvenlafaxine Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 700

157 Dexlansoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2500

158Dextromethorphan +

DextrorphanCough Suppressant Human Plasma K3EDTA LC/MS/MS API 3000

0.10

10.0

20.0

2000

159Dextromethorphan +

Guanafenesin

Cough Suppressant

ExpectorantHuman Plasma K3EDTA LC/MS/MS API 3000

0.10

25.0

20.0

5000

160Diacerein +

Rhein Osteoarthritis Human Plasma K3EDTA LC/MS/MS LCMS-8050

15.0

15.0

6000

6000

161 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 3000 25.0 4000

162 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8040 10.0 4000

163Diclofenac +

Esomeprazole

Analgesic

Proton pump inhibitorHuman Plasma K3EDTA LC/MS/MS API 4000

8.00

4.00

4000

2000

164 Dicloxacillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 200 80000

165 Dihydroartemisinin Anitmalerial Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1000

166 Dihydrotetrabenazine Huntington's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 200

167

Diltiazem +

N-Desmethyl Diltiazem +

Desacetyl Diltiazem

Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000

1.5

0.5

0.5

450

150

150

Page 28 of 65 For more information email: [email protected]

Page 29: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

168

Diltiazem +

N-Desmethyl diltiazem +

Desacetyl diltazem

Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040

4.00

1.00

0.50

1200

300

150

169Diphendydramine +

Naproxen

Sedative antihistamine

NSAIDHuman Plasma K3EDTA LC/MS/MS API 4000

0.50

500

150

150000

170 Dipyridamole Vasodilator Human Plasma K3EDTA LC/MS/MS API 2000 5.00 4500

171 Dipyridamole Vasodilator Human Plasma K3EDTA LC/MS/MS API 2000 5.00 5000

172 Disulfiram Metabolite 2For Chronic Alcoholism

(Disulfiram)Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 250

173 Disulfiram Primary MetaboliteNA (Inactive Metabolite of

Disulfiram)Human Plasma K3EDTA HPLC-UV Shimadzu LC20 2.00 200

174 Dofetilide Antiarrhythmic Human Plasma K3EDTA LC/MS/MS API 4000 0.010 5.00

175 Dolutegravir Antiviral Human Plasma K3EDTA LC/MS/MS API 5500 20.0 8000

176 Donepezil Nootropic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 200

177Donepezil +

MemantineAlzheimer Human Plasma K3EDTA LC/MS/MS API 4000

0.50

0.50

200

200

178 Doxazosin Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 50.0

179Doxepin +

NordoxepinAntidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8040

0.20

0.050

80.0

20.0

180 Doxorubicin (Total) Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 150 60000

Page 29 of 65 For more information email: [email protected]

Page 30: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

181 Doxycycline Antibacterial Human Plasma Na Heparin LC/MS/MS Premier XE 10.0 5000

182 Doxycycline Antibacterial Human Plasma EDTA LC/MS/MS Premier XE 10.0 1500

183 Doxycycline Antibacterial Human Plasma K3EDTA LC/MS/MS API3000 10.0 7000

184 Doxycycline Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 10.0 7000

185Dronedarone+

Desbutyl Dronedarone (Metabolite)Antiarrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE

0.50

0.50

300

300

186 Duloxetine (Sensitive) Antidepressant Human Plasma K3EDTA LC/MS/MS API 2000 0.40 150

187 Duloxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 2000 0.50 100

188 Dutastaride 5-alpha-reductase inhibitor Human Plasma K3EDTA LC/MS/MS API-4000 0.10 25.0

189 Efavirenz Antiviral Human Plasma EDTA HPLC HPLC-UV 50.0 9000

190 Efavirenz Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 30.0 6000

191 Eletriptan Anti-Migraine Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 250

192 Eliglustat Gaucher's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10 100

193 Eltrombopag Thrombocytopenia Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 30000

Page 30 of 65 For more information email: [email protected]

Page 31: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

194 Empagliflozin Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 3.00 1200

195 Emtricitabin Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 30.0 3000

196Emtricitabine +

Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 3000

20.0

4.00

4000

800

197Emtricitabine +

Tenofovir AlafenamideAntiviral Human Plasma K3EDTA LC/MS/MS LCMS-8040

20.0

2.00

5000

500

198Enalapril +

EnalaprilatAntihypertensive Human Plasma EDTA LC/MS/MS API 3000

5.00

2.00

1000

450

199Enalapril +

EnalaprilateAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000

1.00

0.50

500

250

200Entacapone +

Metabolite Antiparkinsonian Human Plasma K3EDTA HPLC HPLC-UV 50.0 6000

201Entacapone +

Metabolite (Sensitive) Antiparkinsonian Human Plasma K3EDTA LC/MS/MS Premier XE 25.0 6000

202 Entecavir Antiviral Human Plasma K3EDTA LC/MS/MS API 5500 0.040 20.0

203 EnzalutamideMetastatic castration-resistant

prostate cancer (CRPC)Human Plasma K3EDTA LC/MS/MS API 2000 10.0 10000

204 Eplerenone Chronic Heart Failure Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 4000

205 Eprosartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 4000

206Eprosartan +

Hydrochlorothiazide

Antihypertensive

DiureticHuman Plasma K3EDTA LC/MS/MS API 3000

30.0

1.00

7500

500

Page 31 of 65 For more information email: [email protected]

Page 32: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

207 Eprosartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 6000

208 Erlotinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 12.5 2500

209 Erlotinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 1.00 2500

210 Erythromycin Antibacterial Human Plasma EDTA LC/MS/MS API 2000 20.0 2000

211 Erythromycin Antimicrobial Human Plasma K3EDTA LC/MS/MSPremier XE /

API400010.0 4000

212 Escitalopram Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.30 200

213 Escitalopram Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 50.0

214Escitalopram +

S (+) DesmethylcitalopramAntidepressant Human Plasma K3EDTA LC/MS/MS API 4000

0.20

0.040

50.0

10.0

215 Eslicarbazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 2000 100 30000

216 Esomeprazole Proton pump inhibitor Human Plasma CPDA, EDTA LC/MS/MS API 2000 10.0 3500

217 Esomeprazole (Sensitive) Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 2000 5.00 3500

218 Esomeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 10.0 4000

219Esomeprazole +

Naproxen

Proton pump inhibitor

NSAIDHuman Plasma K3EDTA LC/MS/MS API 4000

5.0

500

1500

150000

Page 32 of 65 For more information email: [email protected]

Page 33: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

220Esomeprazole+

Naproxen

Proton pump inhibitor

NSAIDHuman Plasma K3EDTA LC/MS/MS API 4000

2.0

500

600

150000

221Ethinyl Esterdiol +

LevonorgetralOestrogen Human Plasma Sodium Heparin LC/MS/MS API 5500

0.004

0.10

0.50

20.0

222 Ethosuximide Anticonvulsant Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 20000

223 Etodolac Non-steroidal Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 500 80000

224 Etodolac Nonsteroidal anti-inflammatory Human Plasma K3EDTA LC/MS/MS Premier XE 250 80000

225 Etoposide Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 20.0 8000

226 Etoricoxib COX-2 selective inhibitor Human Plasma K3EDTA LC/MS/MS API2000 10.0 5000

227 Everolimus Anticancer Human Blood K3EDTA LC/MS/MS API3000 0.30 200

228 Exemestane Aromatase inhibitor, Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.10 40.0

229Ezetimib +

Ezetimibe-O-beta-glucuronideAntihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050

0.10

1.00

25.0

250

230Ezetimibe +

Ezetimibe Phenoxy GlucuronideAntihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

0.10

1.00

30.0

300

231 Ezetimibe(Unconjugated) Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.13 20

232 Ezetimib (Total) Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8040 1.00 200

Page 33 of 65 For more information email: [email protected]

Page 34: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

233Ezetimibe+

Ezetimibe PhenoxygluconorideAntihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000

0.10

1.00

15.0

150

234 Febuxostat Inhibitor of Xanthine Oxidase Human Plasma K3EDTA LC/MS/MS API 4000 50 10000

235 Felodipine Antihypertensive Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 10.0

236 Felodipine Calcium channel blocker Human Plasma K3EDTA LC/MS/MS API 4000 0.10 10.0

237 Fenofibric Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 2000 25.0 10000

238 Fenofibric Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 20000

239 Fenoprofen Non-steroidal Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 3000 250 100000

240Fesoterodine +

5-Hydyroxy methyl tolterodineAntimuscarinic Human Plasma K3EDTA LC/MS/MS API 5500

0.001

0.02

0.750

15.0

241 Fexofenadine Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 2000 8.00 1000

242Fexofenadine +

PseudoephedrineAntihistamine Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1500

243Fexofenedine +

Pseudoephedrine (Sensitive)Antihistamine Human Plasma K3EDTA LC/MS/MS Premier XE

1.00

2.00

500

1000

244 Fingolimod Multiple sclerosis Human Blood K2EDTA LC/MS/MS API 5500 0.010 5.00

245 Flecainide Anti–arrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE 2.00 800

Page 34 of 65 For more information email: [email protected]

Page 35: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

246 Fluconazole Antifungal Human Plasma CPDA, EDTA LC/MS/MS API 2000 50 10000

247 Flucytosine Antimycotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0

248 Flucytosine Antifungal Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0

249 Fluoxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 100

250Fluoxetine +

NorfluoxetineAntidepressant Human Plasma EDTA LC/MS/MS API 4000 2.00 400

251 Fluphenazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.020 5.00

252 Fulvestrant Anticancer Human Plasma K3EDTA LC/MS/MS API3000 0.10 25.0

253 Fulvestrant Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.10 25.0

254 Gabapentin Anticonvulsant Human Plasma EDTA LC/MS/MS API 2000 40.0 10000

255 Gabapentin Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 40.0 6000

256 Gefitinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 250

257 Gefitinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 1.50 450

258 Glibenclamide (Glyburide) Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 1.00 500

Page 35 of 65 For more information email: [email protected]

Page 36: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

259Glibenclamide +

Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050

2.00

10.0

600

3000

260 Gliclazide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 5000

261 Gliclazide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 12000

262 Glimepiride Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 1.00 500

263 Glimpiride Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 1.00 500

264 Glimepiride Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 2.00 800

265 Glipizide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2000

266 Griseofulvin Antifungal Human Plasma K3EDTA LC/MS/MS API 2000 10.0 4000

267 Granisetron Anti–emetic Human Plasma EDTA LC/MS/MS API 2000 0.15 15

268 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS API 2000 43.77 5606

269 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS Premier XE 15.0 6000

270 Guanfacine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.025 10.0

271 Hydralazine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 200

Page 36 of 65 For more information email: [email protected]

Page 37: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

272 Hydrochlorothiazide Diuretic Human Plasma EDTA LC/MS/MS API 2000 5.00 500

273 Hydrochlorothiazide (Sensitive) Diuretic Human Plasma EDTA LC/MS/MS API 3000 1.00 500

274Hydrochlorothiazine +

TelmisartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000

1.50

5.00

300

1000

275 Hydrocortisone Glucocorticoid Human Plasma K3EDTA LC/MS/MS API 4000 0.50 1000

276 Hydroxycarbamide Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 100 30000

277 Hydroxychloroquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 2000 2.00 600

278Hyoscine Butyl Bromide

(Butyl Scopolamine)Abdominal pain Human Plasma K3EDTA LC/MS/MS API 5500 0.002 0.25

279 Ibrutinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 100

280 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 500 100000

281 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 150 30000

282 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 250 100000

283 Idelasisib Chronic lymphocytic leukemia Human Plasma K3EDTA LC/MS/MS API 3200 10.0 4000

284 Imatinib Anticancer Human Plasma K3EDTA LC/MS/MS API2000 25.0 8000

Page 37 of 65 For more information email: [email protected]

Page 38: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

285 Imatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 2000 25.00 6000

286Imatinib +

N-Desmethyl ImatinibAnticancer Human Plasma K3EDTA LC/MS/MS API 3200

20.0

2.00

10000

1000

287 Indapamide Antihypertensive Human Blood K3EDTA LC/MS/MS API 4000 0.20 100

288 Indomethacin Nonsteroidal anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 25.0 5000

289 Indoramin Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.04 80

290Irbesaratan +

Hydrochlorothiazide

Antihypertensive

DiureticHuman Plasma K3EDTA LC/MS/MS API 3000

10.0

1.00

5000

500

291 Isotretinoin Anti-acne Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 2000

292 Isotretinoin Anti-acne Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 1000

293 Itraconazole Antifungal Human Plasma CPDA, EDTA LC/MS/MS API 4000 2.00 600

294Itraconazole +

Hydroxy ItraconazoleAntifungal Human Plasma K3EDTA LC/MS/MS API 3000 2.00 600

295 Ivabradine Heart rate lowering agent Human Plasma K3EDTA LC/MS/MS Premier XE 0.25 100

296Ivabradine +

N-desmethyi ivabradineHeart rate lowering agent Human Plasma K3EDTA LC/MS/MS API 4000

0.20

0.050

100

25.0

297 Ivacaftor Cystic fibrosis Human Plasma K3EDTA LC/MS/MS API 3200 2.00 2000

Page 38 of 65 For more information email: [email protected]

Page 39: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

298 Ketoprofen Anti-Inflammatory, Analgesic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 10000

299 Ketorolac Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2000

300 Ketotifen NSAID Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.002 1.00

301 Lacosamide AED Human Plasma K3EDTA LC/MS/MS LCMS-8040 50.0 10000

302 Labetalol Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 1.0 500

303 Lamivudine Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 60.0 6000

304Lamivudine +

Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 3200

20.0

5.00

4000

1000

305Lamivudine +

ZidovudineAntiviral Human Plasma K3EDTA LC/MS/MS API 2000

40.0

60.0

4000

6000

306Lamivudine +

AbacavirAntiviral Human Plasma EDTA LC/MS/MS API 3000

55.0

30.0

11000

6000

307

Lamivudine +

Nevirapine +

Zidovudine

Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 50.0 6000

308

Lamuvudine +

Nevirapine +

Zidovudine

Antiviral Human Plasma K3EDTA LC/MS/MS API 2000

40.0

50.0

60.0

4000

5000

6000

309 Lamotrigine Anticonvulsant, Anti–epileptic Human Plasma K2EDTA LC/MS/MS Premier XE 40.0 10000

310 Lamotrigine Anticonvulsant, Anti–epileptic Human Plasma K3EDTA LC/MS/MS API 4000 5.00 4000

Page 39 of 65 For more information email: [email protected]

Page 40: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

311 Lansoprazole Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 4000 5.00 2000

312 Lansoprazole (Sensitive) Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 4000 2.00 2000

313 Lansoprazole Proton-pump inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2500

314 Lapatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 10.0 5000

315 Lenalidomide Anticancer (Multiple myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1000

316 Lenalidomide Anticancer (Multiple myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 100

317 Lenvatinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 0.40 400

318 Letrozole Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 100

319 Letrozole Breast Cancer Human Plasma K3EDTA LC/MS/MS API 3200 1.00 400

320 Levetiracetam Anti–epileptic Human Plasma K3EDTA LC/MS/MS Premier XE 300 60000

321 Levetiracetam Anti–epileptic Human Plasma K3EDTA LC/MS/MS Premier XE 300 60000

322 LevocarnitinePrimary systemic carnitine

deficiencyHuman Plasma K3EDTA LC/MS/MS LCMS-8040 100 20000

323 Levocetirizine Non-sedative antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 10.0 600

324 Levofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 16000

Page 40 of 65 For more information email: [email protected]

Page 41: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

325 Levothyroxine Thyroid Hormone Defficiency Human Serum NA LC/MS/MS Premier XE 10.0 1000

326Lidocaine +

PrilocaineLocal Anesthetic Human Plasma K2EDTA LC/MS/MS API 4000

0.60

0.40

300

200

327 Linagliptin Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.035 14.0

328 Linezolid Antibiotic Human Plasma K3EDTA LC/MS/MS API 3000 100 24000

329 Lisinopril Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 1.00 200

330 Lisinopril Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.50 60

331 Lithium Antidepressant Human Plasma K3EDTA ICP OES Optima 8000 50.0 5000

332 Loperamide Antidiarrheal Human Plasma K3EDTA LC/MS/MS API 5500 0.01 4.00

333Loperamide +

N-Desmethyl LoperamideAntidiarrheal Human Plasma K3EDTA LC/MS/MS API 5500

0.010

0.010

4.00

4.00

334Lopinavir +

RitonavirAntiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE

30.0

3.00

15000

1500

335Loratadine +

DesloratadineAntihistamine Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 50

336 Loratadine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.075 25.0

337 Lorcaserin Weight Loss Human Plasma K3EDTA LC/MS/MS API 4000 0.40 200

Page 41 of 65 For more information email: [email protected]

Page 42: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

338 LosartanAngiotensin II Receptor

AntagonistHuman Plasma K3EDTA LC/MS/MS API 3000 1.00 500

339 Lumefantrine Antimalarial Human Plasma Na Heparin LC/MS/MS Premier XE 50.0 20000

340 Lurasidone Antipsychotic Human Serum NA LC/MS/MS API4000 0.25 150

341 Lurasidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.25 150

342 Magnesium Hypomagnesaemia Human Urine NA ICP OES Optima 8000 2000 350000

343 Macitentan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.00 500

344 Maraviroc Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 0.50 500

345 Meclizine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 300

346 Mefenamic Acid (Sensitive) Non-steroidal Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 40.5 12000

347 Mefenamic Acid (Sensitive) Non-steroidal Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 3000 20.0 11000

348 Mefenamic acid Non steroial anti inflammatory Human Plasma K3EDTA LC/MS/MS API2000 30.0 12000

349 Memantine Anti-Alzheimer's Human Plasma EDTA LC/MS/MS API 3000 0.50 100

350 Mercaptopurine Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 4000 0.50 80.0

Page 42 of 65 For more information email: [email protected]

Page 43: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

351 Mesalamine Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 4000 2.00 2000

352 Mesalamine Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 4000 2.00 2000

353 Metaxalone Muscle Relaxant Human Plasma K3EDTA LC/MS/MS API 2000 10.0 5000

354 Metformin Antidiabetic Human Plasma EDTA HPLC HPLC-UV 40.0 7500

355 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 40.0 7500

356 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 7500

357 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 4.00 800

358Metformin +

SitagliptinAntidiabetic Human Plasma K3EDTA LC/MS/MS API 4000

10.0

2.00

4000

800

359 Methenamine Urinary Tract Infection Human Plasma K3EDTA LC/MS/MS API 3200 0.050 20.0

360 Methimazole Antithyroid Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 500

361 Methotrexate antimetabolite and antifolate Human Plasma EDTA LC/MS/MS API 4000 1.00 250

362 Methoxsalen Dermatological Human Plasma EDTA LC/MS/MS API 4000 1.00 200

363 Methoxsalen (Sensitive) Dermatological Human Plasma EDTA LC/MS/MS API 4000 0.10 100

Page 43 of 65 For more information email: [email protected]

Page 44: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

364 Methyl Ergonovine Postpartum Hemorrhage Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.040 10.0

365 Methylphenidate CNS Stimulant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 100

366 Methyl Prednisolone Glucocorticoid Human Plasma K3EDTA LC/MS/MS API 3000 0.20 100

367 Metolazone Metolazone Human Plasma K3EDTA LC/MS/MS API 5500 0.15 150

368Metopimazine +

Metopimazine AcidAntiemetic Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.20

0.40

100

200

369 Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 0.30 300

370 Metoprolol Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.30 300

371 Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.30 300

372 Metronidazole Antiamoebic Human Plasma CPDA, EDTA HPLC HPLC-UV 100 40000

373 Metronidazole Antiamoebic Human Plasma K3EDTA LC/MS/MS Premier XE 100 40000

374 Metronidazole Antiamoebic Human Stool NA LC/MS/MS API-4000 0.50 250

375 Minocycline Antibiotic Human Plasma Na Heparin LC/MS/MS API 4000 10.0 3000

376 Minocycline Antibiotic Human Plasma K2EDTA LC/MS/MS API 4000 10.0 3000

Page 44 of 65 For more information email: [email protected]

Page 45: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

377 Mirabegron Urinary incontinence Human Plasma Na Heparin LC/MS/MS API 5500 0.100 80.0

378 Mono Methyl Fumarate Multiple Sclerosis Human Plasma K3EDTA LC/MS/MS API 3000 10.0 5000

379Montalukast+

Fexofenadin

leukotriene receptor antagonist

AntihistamineHuman Plasma K3EDTA LC/MS/MS API 4000 2.00 1000

380 Montelukast Lukotriene receptor antagonist Human Plasma K3EDTA LC/MS/MS API 4000 5.00 1000

381 Montelukast leukotriene receptor antagonist Human Plasma EDTA LC/MS/MS API 4000 5.00 1000

382 Moxifloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 40.0 5000

383 Moxifloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 40.0 10000

384 Mycophenolic acid Immunosuppressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 300 50000

385 Mycophenolic acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 40.5 20000

386 Mycophenolate Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 40.0 20000

387 Mycophenolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS Premier XE 200 50000

388 Mycophenolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 4000 40.0 20000

389 Mycophenolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 60.0 30000

Page 45 of 65 For more information email: [email protected]

Page 46: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

390 Mycophenolate Mofetil Immunosuppressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 20.0 800

391 Mycophenolate Mofetil Immunosuppressant Human Plasma EDTA LC/MS/MS API 4000 0.10 16.0

392 Mycophenolate Mofetil Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 5500 0.01 10.0

393 Nadolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 1.00 600

394Naltrexone +

6ß Naltrexone Opioid antagonist Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.10

0.50

35.0

175

395 Naproxen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 10.0 10000

396 Naproxen Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 500 150000

397 Naratriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0

398 Nateglinide Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 50.0 12000

399 Nebivolol Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.05 5.00

400 Nebivolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.04 15.0

401 Nifedipine Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.40 200

402 Nefopam Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 200

Page 46 of 65 For more information email: [email protected]

Page 47: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

403 Nefopam Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 200

404 Nevirapine Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 50.00 5000

405 Nilutamide Antiandrogen Human Plasma K3EDTA LC/MS/MS API 4000 40.0 8000

406 Nilotinib Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 6.00 3000

407 NintedanibIdiopathic pulmonary fibrosis

(IPF)Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0

408 Nitrofurantoin Antibiotic Human Plasma EDTA LC/MS/MS API 4000 10.0 1500

409 Nitrofurantoin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 600

410 Nizatidine Antihistamine Human Plasma K3EDTA LC/MS/MS API 4000 20.0 5000

411 Norethisterone (Norethindrone) Progestogen Human Plasma K3EDTA LC/MS/MS API 5500 0.50 100

412 Norfloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 25.0 8000

413 Nortriptyline Antidepressant Human Plasma EDTA LC/MS/MS API 3000 0.50 220

414 Nortriptyline Antidepressant Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 50.0

415 Ofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 25.0 8000

Page 47 of 65 For more information email: [email protected]

Page 48: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

416 Olanzapine Antipsychotic Human Plasma EDTA LC/MS/MS API 3000 0.50 50.0

417 OlmesartanAngiotensin II receptor

antagonistHuman Plasma K3EDTA LC/MS/MS API 4000 10.0 3000

418Olmesartan +

Hydrochlorothiazide

Angiotensin II receptor

antagonist

Diuretic

Human Plasma K3EDTA LC/MS/MS API 400010.0

1.00

3000

300

419 Olanzepine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0

420 Olanzapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3200 0.30 120

421 Olsalazine Ulcerative colitis Human Plasma K3EDTA LC/MS/MS API 4000 20.0 2000

422 Omeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2000

423 Omeprazole Proton Pump Inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 2.00 2000

424 Ondansetron Anti–emetic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 80.0

425 Orphenadrine Antihistamine Human Plasma K3EDTA LC/MS/MS API 2000 4.00 800

426Oseltamivir +

Oseltamivir CarobxylateAntiviral Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.50

2.00

250

1000

427Oseltamivir +

Oseltamivir CarboxylateAntiviral Human Plasma K3EDTA LC/MS/MS API 3000

0.50

2.00

200

800

428 Ospemifene Dyspareunia Human Serum NA LC/MS/MS LCMS-8040 5.00 2000

Page 48 of 65 For more information email: [email protected]

Page 49: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

429 Oxaprozin Total NSAID Human Plasma K3EDTA LC/MS/MS LCMS-8040 500 160000

430

Oxcarbazepine +

10, 11-Dihydro-10-hydroxy-

Carbamazepine

Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 200020.0

75.0

4000

15000

431Oxybutynin +

Metabolite- N-Desethyl OxybutyninAnticholinergic Human Plasma K3EDTA LC/MS/MS API 4000

0.05

0.50

10.0

100

432 Paclitaxel (Total) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 5.00 15000

433 Paclitaxel (Total) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 80.0 40000

434 Palbociclib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200

435 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 150

436 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 50.0

437 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.050 50.0

438 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 250

439 Pantoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 15.0 5000

440 Pantoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 10.0 6000

441 Paracetamol Antipyretic Human Plasma K3EDTA LC/MS/MS API 3000 200 20000

Page 49 of 65 For more information email: [email protected]

Page 50: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

442 Paroxetin Antidepressant Human Plasma K3EDTA LC/MS/MS API 3000 0.40 200

443 Paroxetine Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 2000 0.40 60.0

444 Pazopanib Anticancer Human Plasma K2EDTA LC/MS/MS API 4000 100 40000

445 Pemetrexed Lung Cancer Human Plasma K3EDTA LC/MS/MS API 3200 500 200000

446 Perampanel Antiepileptic Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 1000

447 Phenobarbital AEDs Human Plasma K2EDTA LC/MS/MS Premier XE 10.00 4000

448 Phloroglucinol Antispasmodic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2500

449 Pimozide Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.02 5.00

450 Pindolol Beta Blocker Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400

451Pioglitazone +

Hydroxy Pioglitazone M IV Antihyperglycemic, antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000

10.0

5.00

3000

1500

452 Piperaquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 4000 2.00 300

453 Pirfenidone Idiopathic pulmonary fibrosis

(IPF)Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 25000

454 Piroxicam NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 10000

Page 50 of 65 For more information email: [email protected]

Page 51: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

455 Pomalidomide Anticancer (Multiple Myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 150

456 Posaconazole Antifungal Human Plasma K3EDTA LC/MS/MS API3000 2.00 2000

457 Pramipexole Antiparkinsonian Human Plasma EDTA LC/MS/MS API 4000 0.02 4.00

458 Pravastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.40 200

459 Pravastatin Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.30 200

460 Praziquantel Anthelmintic Human Plasma K3EDTA LC/MS/MS API 3000 10.0 4000

461 Pregabalin Anticonvulsant Human Plasma K3EDTA LC/MS/MS Premier XE 30.0 15000

462 Pregabalin Anticonvulsant Human Plasma K3EDTA LC/MS/MS Premier XE 30.0 15000

463

Pregabalin+

Gabapentin+

Carbamazepine+

Levetiracetam

AEDs Human Plasma K2EDTA LC/MS/MS Premier XE

30.0

100

10.0

60.0

6000

20000

2000

120000

464 Primaquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 3200 0.50 200

465 Primidone Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 50.00 40000

466Propafenone+

5-Hydroxy PropafenoneAntiarrhythmic Human Plasma K3EDTA LC/MS/MS API 4000

0.20

0.20

400

400

467 Pottasium Hypokalaemia Human Urine NA ICP OES Optima 8000 20000 3000000

Page 51 of 65 For more information email: [email protected]

Page 52: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

468 Prasugrel Metabolite R95913 Platelet Inhibitor (Prasugrel) Human Plasma K2EDTA LC/MS/MS API 4000 0.50 100

469 Prochlorperazine Tranquilliser Human Plasma K3EDTA LC/MS/MS API 5500 0.002 0.600

470 Proguanil Antimalarial Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000

471 Promethazine Antihistaminic Human Plasma K3EDTA LC/MS/MS API2000 0.20 60.0

472 Propofol Sedative-hypnotic Human Plasma K3EDTA LC/MS/MS API 5500 5.00 5000

473Propafenone +

5-Hydroxy metaboliteAnti-arrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE

5.00

2.50

1000

500

474Propranolol +

4-Hydroxy Propranolol(Free)Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000

0.10

0.30

100

30.0

475 Pyrazinamide Antitubercular Human Plasma Na Heparin LC/MS/MS LCMS-8050 200 60000

476 Quetiapine Antipsychotic Human Plasma EDTA LC/MS/MS Premier XE 2.00 2000

477 Quetiapine Antipsychotic Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 200

478 Quetiapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 600

479 Quinine Antimalarial Human Plasma K3EDTA LC/MS/MS API 2000 40.0 8000

480 Rabeprazole Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 2000 3.00 2000

Page 52 of 65 For more information email: [email protected]

Page 53: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

481 Rabeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 3.00 1000

482 Raltegravir Antiretroviral Human Plasma K3EDTA LC/MS/MS API 4000 20.0 10000

483 Ramipril Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 0.20 100

484Ramipril+

RamiprilatAntihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100

485 Ranitidine Antihistamine Human Plasma EDTA LC/MS/MS API 2000 5.00 1000

486 Ranitidine Antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 10.0 3000

487 Ranolazine Antianginal Human Plasma K3EDTA LC/MS/MS Premier XE 4.00 8000

488 Rasagiline Parkinsons disease plasma K3EDTA LC/MS/MS Waters 0.02 10.0

489 Repaglinide Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 0.50 200

490 Rifaximin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 0.025 10.0

491 RilpivirinNon-nucleoside Reverse

Transcriptase InhibitorHuman Plasma K3EDTA LC/MS/MS API 2000 2.00 500

492Risperidone +

9-Hydroxy RisperidoneAntipsychotic Human Plasma K3EDTA LC/MS/MS Premier XE

0.20

0.20

100

100

493 Ritonavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 2.50 1500

Page 53 of 65 For more information email: [email protected]

Page 54: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

494 Rivoroxaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS API 2000 1.00 800

495 Rivaroxaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 500

496 RivastigmineAlzheimer's&Parkinson's

DiseaseHuman Plasma K3EDTA LC/MS/MS Premier XE 0.10 50.0

497 Rizatriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 100

498 Rizatriptan Anti-Migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 60.0

499Roflumilast +

Roflumilast N-Oxide

Severe COPD associated with

chronic bronchitisHuman Plasma K3EDTA LC/MS/MS Premier XE

0.20

0.25

40.0

50.0

500 Ropinirole Antiparkinsonian Human Plasma EDTA LC/MS/MS API 4000 0.02 4.00

501 Ropinirole Antiparkinsonian Human Plasma K3EDTA LC/MS/MS API 4000 0.02 4.00

502Rosiglitazone +

MetforminAntidiabetic Human Plasma EDTA LC/MS/MS API 2000

6.00

40.0

1100

7600

503Rosiglitazone +

N-Desmethyl RosiglitazoneAntidiabetic Human Plasma K3EDTA LC/MS/MS API 2000

5.00

2.50

1000

500

504 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS Premier XE 0.60 100

505 Rosuvastatin Lowering Cholesterol Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 150

506 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200

Page 54 of 65 For more information email: [email protected]

Page 55: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

507 Rufinamide Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 30.0 9000

508 S-Amlodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03 12.0

509S-Amlodipine+

Hydrochlorothiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS API4000

0.03

1.00

12.0

400

510S-Amlodipine +

Hydrochlorothiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS API4000

0.03

1.00

12.0

400

511 Scopolamine Anticholinergic Human Plasma K3EDTA LC/MS/MS API 4000 0.005 0.50

512 Secnidazole Antiamoebic Human Plasma K3EDTA LC/MS/MS API 3200 200 80000

513 Sertraline Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 2000 1.50 300

514 Sertraline Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.20 80.0

515 SildenafilAntihypertensive, Erectile

dysfunctionHuman Plasma K3EDTA LC/MS/MS API 3000 8.00 1040

516Sildenafil +

Metabolite

Antihypertensive, Erectile

dysfunctionHuman Plasma K3EDTA LC/MS/MS API 3000 2.00 1000

517Sildenafil +

Piperazine N-desmethyl Sildenafil

Antihypertensive, Erectile

dysfunctionHuman Plasma K3EDTA LC/MS/MS API 3000

5.00

1.00

2000

400

518Sildenafil +

N-desmethyl sildenafil

Antihypertensive, Erectile

dysfunctionHuman Plasma K3EDTA LC/MS/MS API 4000

1.00

0.20

500

100

519Silodosin +

Silodsoin GlucuronideBenign prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS LCMS-8050

0.50

0.40

300

240

Page 55 of 65 For more information email: [email protected]

Page 56: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

520Simvastatin +

β - hydroxy AcidAntihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.50 100

521Simvastatin +

β - hydroxy AcidAntihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.25 32.0

522Simvastatin +

Simvastatin acidAntihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000

0.200

0.200

100

100

523Simvastatin +

Simvastatin AcidAntihyperlipidemic Human Plasma Na Heparin LC/MS/MS API 4000

0.50

0.50

200

200

524 Siimvastatin Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.040 20.0

525 Simvastatin Acid Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.02 7.50

526 Sirolimus Immunosuppressant Human Blood EDTA LC/MS/MS API 4000 0.40 40.0

527 Sirolimus (Sensitive) Immunosuppressant Human Blood K3EDTA LC/MS/MS Premier XE 0.10 50.0

528 Sitagliptin Antihyperglycemic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 800

529

Sodium Phenyl Butyrate +

Metabolite Phenyl acetate+

Metabolite Phenylacetylglutamine

For Urea cycle disorders Human Plasma K3EDTA LC/MS/MS API 2000

5 µg/mL

1 µg/mL

2 µg/mL

750 µg/mL

750µg/mL

300 µg/mL

530 Sofosbuvir Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8040 5.00 2000

531Sofosbuvir +

Sofosbuvir GS331007Antiviral Human Plasma K3EDTA LC/MS/MS LC 8040

5.00

10.0

1500

3000

532 Solifenacin Urinary antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 125

Page 56 of 65 For more information email: [email protected]

Page 57: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

533 Solifenacin (Sensitive) Antimuscarinic Human Plasma K3EDTA LC/MS/MS API 4000 0.20 130

534 Sorafenib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 10000

535 Sotalol Antiarrhythmic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 3000

536 Sulfadiazine Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 250 40000

537Sulphamethoxazole +

Trimethoprim Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000

0.50

0.025

100

5.00

538 Sumatripatan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100

539 Sunitinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.25 100

540 Tacrolimus Immunosuppressant Human Blood EDTA LC/MS/MS Premier XE 0.50 100

541 Tacrolimus Immunosuppressant Human Blood EDTA LC/MS/MS Premier XE 0.25 75.0

542 Tacrolimus Immunosuppressant Human Blood K3EDTA LC/MS/MS LCMS-8050 0.050 75.0

543 TadalafilAntihypertensive, Erectile

dysfunctionHuman Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 800

544 Tamsulosin Prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050 30.0

545 Tamsulosin α1a-selective alpha blocker Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100

Page 57 of 65 For more information email: [email protected]

Page 58: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

546 Tapentadol Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10 200

547 Telmisartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 3.00 1200

548 Telmisartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 5.00 1000

549 Telmisartan Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 500

550Telmisartan +

AmlodipineAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000

2.50

0.075

500

15.0

551 Temozolamide Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 100 20000

552 Temozolomide Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 100 20000

553 Tenofovir Antiviral Human Serum NA LC/MS/MS API 4000 5.00 1000

554 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 5.00 1000

555 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.40 50.0

Page 58 of 65 For more information email: [email protected]

Page 59: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

556

Tenofovir +

Emtricitabine +

Lamivudine

Antiviral Human Plasma EDTA LC/MS/MS API 4000

4.00

15.0

20.0

800

3000

4000

557 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 5.00 1000

558Tenofovir+

Emtricitabine Antiviral Human Plasma K3EDTA LC/MS/MS API 2000

8.00

30.0

1600

6000

559

Tenofovir +

Emtricitabine +

Rilpivirine

Antiritroviral Human Plasma K3EDTA LC/MS/MS API 4000

4.00

20.0

1.00

800

4000

200

560

Tenofovir +

Emtricitabine +

Nevirapine

Antiritroviral Human Plasma K3EDTA LC/MS/MS API 4000

4.00

20.0

20.0

800

4000

4000

561 Tenofovir Alafenamide Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 1000

562Tenofovir Alafenamide +

LamivudineAntiviral Human Plasma K3EDTA LC/MS/MS API 3200

2.00

20.0

500

5000

563 Terbinafine Antifungal Human Plasma EDTA HPLC HPLC-UV 25.0 5000

564 Terbinafine Antifungal Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 3000

565 Teriflunomide Multiple sclerosis Human Plasma K3EDTA LC/MS/MS API 3000 10.0 4000

566 Tetrabenazine Huntington's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.01 2.00

567 Tetracycline Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 20.0 8000

Page 59 of 65 For more information email: [email protected]

Page 60: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

568 Tiagabine Anticonvulsant Human Plasma EDTA LC/MS/MS API 4000 0.50 250

569 Ticagrelor Platelet aggregation inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 2.50 1200

570 Tinidazole Antiprotozoal Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 30000

571 Tizanidine Muscle Relexant Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0

572 Tizanidine Muscle Relexant Human Plasma K3EDTA LC/MS/MS Premier XE 0.075 20.0

573 Tofacitinib Rheumatoid arthritis Human Plasma K3EDTA LC/MS/MS API 3200 0.20 100

574Tolcapone +

3-O-Methyltolcapone

Reversible inhibitor of catechol-

O-methyltransferase (COMT)Human Plasma K3EDTA LC/MS/MS API 4000

40.0

2.00

8000

400

575 Tolterodine Antimuscarinic Human Plasma EDTA LC/MS/MS API 3000 0.10 20.0

576Tolterodine +

5-Hydroxy Methyl TolterodineAntimuscarinic Human Plasma EDTA LC/MS/MS API 3000 0.03 10.0

577Tolterodine+

5-Hydroxymethyl TolterodineAntimuscarinic Human Plasma K3EDTA LC/MS/MS API 3000

0.025

0.025

10.0

10.0

578 Topiramate Anticonvulsant Human Plasma CPDA, EDTA LC/MS/MS API 4000 18.0 5000

579 Topiramate (Sensitive) Anticonvulsant Human Plasma EDTA LC/MS/MS API 4000 5.00 5000

580 Torsemide Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 20.0 6000

Page 60 of 65 For more information email: [email protected]

Page 61: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

581 Total Iron Iron Defficiency Anaemia Human Serum NA ICP OES Optima 8000 500 60000

Page 61 of 65 For more information email: [email protected]

Page 62: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

582 Tramadol hydrochloride Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8050 3.00 750

583 Trametinib Anticancer Human Plasma K2EDTA LC/MS/MS LCMS-8050 0.25 250

584 Transferrin Bound Iron NA Human Serum NA ICP OES Optima 8000 200 8000

585 Transerrin Bound Iron

For Estimation of transferrin

bound Iron after Ferrmoxytol

and Ferric carboxy maltose

therapy

Dog Serum NA ICP OES Optima 8000 500 20000

586 Tranylcypromine Antidepressant and Anxiolytic Human Plasma K3EDTA LC/MS/MS API 4000 0.30 150

587 Trazodone Antidepressant Human Plasma EDTA LC/MS/MS API 4000 10.0 3000

588 Trazodone Antidepressant Human Plasma EDTA LC/MS/MS API 3000 10.0 3000

589 Trifluoperazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 8.00

590 Trimetazidine Antianginal Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 202

591 Trimethyl Phloroglucinol Antispasmodic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2500

592 Trospium Urinary Antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0

593 Trospium (Sensitive) Urinary Antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.02 10.0

Page 62 of 65 For more information email: [email protected]

Page 63: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

594 Ulipristal Acetate Contraceptive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 160

595Valacyclovir +

AcyclovirAntiviral Human Plasma K3EDTA LC/MS/MS API 4000

5.00

50.0

1000

10000

596Valacyclovir +

AcyclovirAntiviral Human Plasma K3EDTA LC/MS/MS API 4000

5.00

50.0

1000

10000

597Valganciclovir +

Ganciclovirantiviral Human Plasma K3EDTA LC/MS/MS Premier XE

2.00

20.0

1000

10000

598 Valproic acid Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 400 40000

599 Valproic Acid Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 1000 150000

600 Valproic acid Anticonvulsant Human Plasma K2EDTA LC/MS/MS API 4000 1000 100000

601 Valproic Acid Anticonvulsant Human Plasma EDTA LC/MS/MS API 2000 1000 100000

602 Valsartan Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 5.00 5000

603 Valsartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 20.0 12000

604Valsartan +

Hydrochlorothiazide

Angiotension II Receptor

Antagonist

Diuretic

Human Plasma K3EDTA LC/MS/MS API 400040.0.

1.00

12000

300

605 Venetoclax Chronic lymphocytic leukemia Human Plasma K3EDTA LC/MS/MS API 5500 10.0 3000

606Venlafaxine +

O - Desmethyl Venlafaxine Antidepressant Human Plasma EDTA LC/MS/MS API 4000

2.00

3.00

500

750

Page 63 of 65 For more information email: [email protected]

Page 64: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

607Venlafexine (Sensitive) +

O - Desmethyl VenlafaxineAntidepressant Human Plasma K3EDTA LC/MS/MS API 4000

0.25

0.50

100

200

608Verapamil +

NorverapamilAntihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040

2.00

2.00

500

500

609 Vertaric acidAntihypertensive and

AntioxidantHuman Plasma K3EDTA LC/MS/MS API 4000 100.00 20000

610 Vildagliptin Anti diabetic Human Plasma K3EDTA LC/MS/MS API2000 2.00 800

611Vidagliptin +

MetforminAntidiabetic Human Plasma K3EDTA LC/MS/MS API 4000

2.00

10.0

800

4000

612 Vilazodone Antidepressant Human Plasma K3EDTA LC/MS/MS API2000 0.30 60

613 Voriconazole(Sensitive) Antifungal Human Plasma EDTA LC/MS/MS API 3000 30.00 9000

614 Voriconazole (Sensitive) Antifungal Human Plasma K3EDTA LC/MS/MS API 3000 25.00 5000

615 Voriconazole Antifungal Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000

616 Vortioxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.05 20.0

617 Zidovudine Antiviral Human Plasma EDTA HPLC HPLC-UV 75.00 6000

618 Zidovudine (Sensitive) Antiviral Human Plasma Na Heparin HPLC HPLC-UV 20.00 4000

619 Zinc (Zinc Acetate)Inhibit the absorption of copper

in Wilson's diseaseHuman Plasma K3EDTA ICP OES Optima 8000 300 25000

Page 64 of 65 For more information email: [email protected]

Page 65: Veeda Clinical Research Pvt. Ltd. · 2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000 3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500

Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library

Sr.

No. Drug Name Theraputic Class Matrix

Anti-

Coagulant Method Equipment

LLOQ

(ng/mL)

ULOQ

(ng/mL)

Validated Method List (Generics)

620 Zolpidem Insomnia Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 300

621 Zonisamide Antiepileptic Human Serum NA LC/MS/MS API 3200 10.0 3000

622

Zonisamide+

Topiramate +

Oxcarbazepine+

Phenytoin

Antiepileptic Human Plasma K2EDTA LC/MS/MS Premier XE

300

100

10.0

60.0

6000

20000

2000

12000

623 Zopiclone Hypnotic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 200

Validated Methods (Generics)Method Library -

NCE

PD /

Immunogenicity

Recently Validated

(Generics)

Recently

Validated (NCE)

Premium

Methods

(Generics)

Under

Development

/ Validation

623 60 16 4 1 50 23

Total

Methods754

Page 65 of 65 For more information email: [email protected]